RGLS - Regulus Therapeutics Inc.

QQQ $ 469.10 $ 0.47 (0.1 %)

DIA $ 409.67 $ 0.21 (0.05 %)

SPY $ 554.87 $ -0.12 (-0.02 %)

TLT $ 100.24 $ -0.13 (-0.13 %)

GLD $ 235.37 $ 0.73 (0.31 %)

Previous Close

$ 1.54

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.08 - $ 3.79

Volume

168,597

Average Volume

Market Cap

100.82M

Beta (5Y Monthly)

$ 0.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-21-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-23-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-10-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-14-2021	03-31-2021	10-Q
15	03-09-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-13-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	03-18-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-08-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-02-2017	06-30-2017	10-Q
30	05-05-2017	03-31-2017	10-Q
31	03-03-2017	12-31-2016	10-K
32	11-02-2016	09-30-2016	10-Q
33	08-03-2016	06-30-2016	10-Q
34	05-03-2016	03-31-2016	10-Q
35	02-23-2016	12-31-2015	10-K
36	11-06-2015	09-30-2015	10-Q
37	08-05-2015	06-30-2015	10-Q
38	05-08-2015	03-31-2015	10-Q
39	02-19-2015	12-31-2014	10-K
40	11-06-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Reiterates Outperform on Regul...
08/14/2024 17:36:28

Oppenheimer analyst Andreas Argyrides reiterates Regulus Therapeutics (NASDAQ:RGLS) with a Outperform and maintains $7 price...

HC Wainwright & Co. Reiterates Buy on Regu...
08/09/2024 21:26:15

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Regulus Therapeutics (NASDAQ:RGLS) with a Buy and maintains $1...

Regulus Therapeutics Q2 EPS $(0.17) Misses...
08/08/2024 21:34:02

Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate o...

HC Wainwright & Co. Reiterates Buy on Regu...
07/16/2024 12:11:18

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Regulus Therapeutics (NASDAQ:RGLS) with a Buy and maintains $1...

Canaccord Genuity Maintains Buy on Regulus...
06/25/2024 14:49:33

Canaccord Genuity analyst Whitney Ijem maintains Regulus Therapeutics (NASDAQ:RGLS) with a Buy and raises the price target f...

ball-to-rally-more-than-23-here-are-10-top-analyst-forecasts-for-tuesday

Ball To Rally More Than 23%? Here Are 10 T...
06/25/2024 11:27:06

HC Wainwright & Co. Maintains Buy on Regul...
06/25/2024 10:48:46

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Regulus Therapeutics (NASDAQ:RGLS) with a Buy and raises the pr...

whats-going-on-with-regulus-therapeutics-stock-monday

What's Going On With Regulus Therapeutics ...
06/24/2024 15:32:28

Regulus Therapeutics announced positive results from its study related to the treatment of autosomal dominant polycystic kidney...

Market-Moving News for June 24th
06/24/2024 12:39:04

ALNY: 14% | Alnylam Pharmaceuticals shares are trading higher after the company announced topline results from its HELIOS-B Pha...

Regulus Therapeutics shares are trading hi...
06/24/2024 11:43:56

Regulus Therapeutics Announces Results in ...
06/24/2024 11:10:00

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and development of innovative med...

Regulus Therapeutics Announces Expected Ad...
06/04/2024 12:13:04

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and development of innovative med...

Jones Trading Initiates Coverage On Regulu...
05/31/2024 12:58:47

Jones Trading analyst Catherine Novack initiates coverage on Regulus Therapeutics (NASDAQ:RGLS) with a Buy rating and announ...

Bio-Techne And Regulus Therapeutics Announ...
05/22/2024 11:11:41

HC Wainwright & Co. Reiterates Buy on Regu...
05/10/2024 11:51:47

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Regulus Therapeutics (NASDAQ:RGLS) with a Buy and maintains $9...

Regulus Therapeutics Q1 2024 GAAP EPS $(0....
05/09/2024 21:36:58

Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate o...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
05/06/2024 20:31:06

HC Wainwright & Co. Reiterates Buy on Regu...
05/06/2024 18:02:10

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Regulus Therapeutics (NASDAQ:RGLS) with a Buy and maintains $9...

Regulus Therapeutics Advances To Cohort 4 ...
05/06/2024 12:15:53

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and development of innovative med...

HC Wainwright & Co. Reiterates Buy on Regu...
03/25/2024 10:16:39

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Regulus Therapeutics (NASDAQ:RGLS) with a Buy and maintains $9...